Latest Institutional Purchases of Celyad Oncology Sa (CYAD)
This list provides information on the latest institutional transactions involving Celyad Oncology Sa (CYAD) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Baader Bank Aktiengesellschaft
Unterschleissheim, 2M |
BUY
|
- |
18.3KNew |
$0 - $17.5K
|
18.3K
$9.5K
|
|
|
Aug 08, 2023
Q2 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
9KNew |
$0 - $8.64K
|
9K
$4.68K
|
|
| Q1 2023 | |||||||
|
May 15, 2023
Q1 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
11KNew |
$5.52K - $26.1K
|
11K
$5.74K
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
| Q4 2022 | |||||||
|
Feb 14, 2023
Q4 2022
|
Old Mission Capital LLC
|
BUY
|
- |
16.3KNew |
$8K - $17.6K
|
16.3K
$8.49K
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
11KNew |
$5.39K - $11.9K
|
11K
$5.72K
|
|
| Q3 2022 | |||||||
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
11.6KNew |
$18.2K - $28.4K
|
11.6K
$6.03K
|
|
| Q2 2022 | |||||||
|
Aug 12, 2022
Q2 2022
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
- |
838New |
$1.3K - $1.94K
|
838
$436
|
|
| Q4 2021 | |||||||
|
Feb 14, 2022
Q4 2021
|
Fortress Investment Group LLC
New York, NY |
BUY
|
- |
6.5MNew |
$23.1M - $32.5M
|
6.5M
$3.38M
|
|
|
Jan 24, 2022
Q4 2021
|
National Bank Of Canada
|
BUY
|
- |
3.4KNew |
$12.1K - $17K
|
3.4K
$1.77K
|
|
| Q2 2018 | |||||||
|
Nov 08, 2023
Q2 2018
|
Eversept Partners, LP
New York, NY |
BUY
|
- |
12.8KNew |
$334K - $451K
|
12.8K
$6.68K
|
|